Abstract
Boron neutron capture therapy (BNCT) is a promising treatment for malignant brain tumors as well as other cancers. Current research centers on both the design and synthesis of high boron containing compounds as BNCT agents, and the search for more effective delivery vehicles. This review discusses recent work on the development of nanomaterial based BNCT agents.
Keywords: Boron neutron capture therapy (BNCT), liposome, dendrimer, single-/multi-wall carbon nanotube (S/MWCNT), magnetic nanoparticle
Current Chemical Biology
Title: Recent Developments in Boron Neutron Capture Therapy (BNCT) Driven by Nanotechnology
Volume: 1 Issue: 2
Author(s): Zhu Yinghuai, Koh Cheng Yan, John A. Maguire and Narayan S. Hosmane
Affiliation:
Keywords: Boron neutron capture therapy (BNCT), liposome, dendrimer, single-/multi-wall carbon nanotube (S/MWCNT), magnetic nanoparticle
Abstract: Boron neutron capture therapy (BNCT) is a promising treatment for malignant brain tumors as well as other cancers. Current research centers on both the design and synthesis of high boron containing compounds as BNCT agents, and the search for more effective delivery vehicles. This review discusses recent work on the development of nanomaterial based BNCT agents.
Export Options
About this article
Cite this article as:
Yinghuai Zhu, Cheng Yan Koh, Maguire A. John and Hosmane S. Narayan, Recent Developments in Boron Neutron Capture Therapy (BNCT) Driven by Nanotechnology, Current Chemical Biology 2007; 1 (2) . https://dx.doi.org/10.2174/2212796810701020141
DOI https://dx.doi.org/10.2174/2212796810701020141 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Silymarin Extends Lifespan and Reduces Proteotoxicity in C. elegans Alzheimer’s Model
CNS & Neurological Disorders - Drug Targets Destroying RNA as a Therapeutic Approach
Current Medicinal Chemistry Designing of Novel Carbonic Anhydrase Inhibitors and Activators
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Preface: The Wealth of microRNA Kingdom: From Plant Defense to Cancer Prevention
MicroRNA Scaffolds for Blocking Protein-Protein Interactions
Current Topics in Medicinal Chemistry Advances of Infrared Spectroscopic Imaging and Mapping Technologies of Plant Material
Current Bioactive Compounds Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design Tissue-Specific Methylation of Long Interspersed Nucleotide Element-1 of Homo Sapiens (L1Hs) During Human Embryogenesis and Roles in Neural Tube Defects
Current Molecular Medicine Deoxypodophyllotoxin Isolated from Juniperus communis Induces Apoptosis in Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Anticancer Activities and Mechanisms of Bisdioxopiperazine Compounds Probimane and MST-16
Anti-Cancer Agents in Medicinal Chemistry Changes in Glutathione, Oxidative Stress and Mitochondrial Membrane Potential in Apoptosis Involving the Anticancer Activity of Cantharidin Isolated from Redheaded Blister Beetles, Epicauta hirticornis
Anti-Cancer Agents in Medicinal Chemistry Disorders of Sex Development: A Review
Current Women`s Health Reviews Selectively Replicating Adenoviruses for Oncolytic Therapy
Current Cancer Drug Targets Anti-Cancer Therapies that Utilize Cell Penetrating Peptides
Recent Patents on Anti-Cancer Drug Discovery Protein Kinases as Tumor Biomarkers and Therapeutic Targets
Current Pharmaceutical Design Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design Angiogenesis: A Target for Cancer Therapy
Current Pharmaceutical Design Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects
Current Cancer Drug Targets The Immunohistochemical Assessment of HPV Related Adenocarcinoma: Pathologic and Clinical Prognostic Significance
Current Pharmaceutical Design A Review of Surgical Options to Preserve Fertility in the Treatment of Early Cervical Cancer
Current Women`s Health Reviews